These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1360255

  • 1. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
    Smith EF, Slivjak MJ, Gagnon R.
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):499-504. PubMed ID: 1360255
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ, Gellai M, Ruffolo RR.
    Fundam Clin Pharmacol; 1991 Oct; 5(1):25-38. PubMed ID: 1712335
    [Abstract] [Full Text] [Related]

  • 3. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C, Cattaneo BM, Seravalle G, Carugo S, Mangoni AA, Grassi G, Zanchetti A, Mancia G.
    J Cardiovasc Pharmacol; 1992 Oct; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.
    Abbott JA, Broadstone RV, Ward DL, Pyle RL.
    Am J Vet Res; 2005 Apr; 66(4):637-41. PubMed ID: 15900944
    [Abstract] [Full Text] [Related]

  • 5. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B, Bompart F, Graham BR, Liu JB, Prichard BN.
    Drugs; 1988 Apr; 36 Suppl 6():37-47. PubMed ID: 2908303
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of catecholamines on function of the rat right heart.
    Irlbeck M, Zimmer HG.
    Cardiovasc Res; 1993 Dec; 27(12):2146-51. PubMed ID: 7906201
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
    Sponer G, Bartsch W, Strein K, Müller-Beckmann B, Böhm E.
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic profile of carvedilol.
    van Zwieten PA.
    Cardiology; 1993 Mar; 82 Suppl 3():19-23. PubMed ID: 8106159
    [Abstract] [Full Text] [Related]

  • 9. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 10. Dose-effect and pharmacokinetic-pharmacodynamic relationships of the beta 1-adrenergic receptor blocking properties of various doses of carvedilol in healthy humans.
    de Mey C, Breithaupt K, Schloos J, Neugebauer G, Palm D, Belz GG.
    Clin Pharmacol Ther; 1994 Mar 28; 55(3):329-37. PubMed ID: 7908256
    [Abstract] [Full Text] [Related]

  • 11. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR.
    Chirality; 1989 Mar 28; 1(4):265-70. PubMed ID: 2577144
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular and renal effects of carvedilol in dogs with heart failure.
    Uechi M, Sasaki T, Ueno K, Yamamoto T, Ishikawa Y.
    J Vet Med Sci; 2002 Jun 28; 64(6):469-75. PubMed ID: 12130829
    [Abstract] [Full Text] [Related]

  • 13. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T, Ishibashi T, Nakazawa M, Satoh S, Imai S.
    J Cardiovasc Pharmacol; 1990 Jul 28; 16(1):147-53. PubMed ID: 1696657
    [Abstract] [Full Text] [Related]

  • 14. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR.
    Pharmacology; 1989 Jul 28; 39(5):327-36. PubMed ID: 2575762
    [Abstract] [Full Text] [Related]

  • 15. Norepinephrine-induced changes in rat heart function, metabolism, and weight are antagonized by carvedilol.
    Nagano T, O'Harrow S, Sponer G, Zimmer HG.
    J Cardiovasc Pharmacol; 1993 Apr 28; 21(4):530-6. PubMed ID: 7681896
    [Abstract] [Full Text] [Related]

  • 16. The effects of losartan and captopril on vasopressor actions of cirazoline in the absence and presence of SZL-49 and nifedipine.
    Tabrizchi R, Lupichuk SM.
    J Cardiovasc Pharmacol; 1995 Jul 28; 26(1):137-44. PubMed ID: 7564355
    [Abstract] [Full Text] [Related]

  • 17. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
    Qvigstad E, Sjaastad I, Bøkenes J, Schiander I, Solberg L, Sejersted OM, Osnes JB, Skomedal T.
    Eur J Pharmacol; 2005 May 23; 516(1):51-9. PubMed ID: 15916756
    [Abstract] [Full Text] [Related]

  • 18. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
    Horio T, Ito S, Aoyama M, Takeda Y, Suzumura H, Nakata K, Yamada Y, Suzuki S, Fukutomi T, Itoh M.
    Eur J Pharmacol; 2001 Jan 26; 412(2):145-53. PubMed ID: 11165226
    [Abstract] [Full Text] [Related]

  • 19. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K, Harada N, Uchiba M, Isobe H.
    J Pharmacol Exp Ther; 2004 May 26; 309(2):684-91. PubMed ID: 14764656
    [Abstract] [Full Text] [Related]

  • 20. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H, Sakabe A, Maehara K, Maruyama Y.
    Circulation; 2002 Feb 26; 105(8):975-80. PubMed ID: 11864928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.